EDGAR Filing Documents for 0001193125-18-333095

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-18-333095

Filing Date

2018-11-23

Accepted

2018-11-23 16:02:39

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	d656789ds3.htm	S-3	240372
2	EX-3.1	d656789dex31.htm	EX-3.1	23854
3	EX-4.6	d656789dex46.htm	EX-4.6	314339
4	EX-4.7	d656789dex47.htm	EX-4.7	309874
5	EX-5.1	d656789dex51.htm	EX-5.1	14364
6	EX-23.1	d656789dex231.htm	EX-23.1	1607
7	GRAPHIC	g656789g62h66.jpg	GRAPHIC	23749
8	GRAPHIC	g656789g81r22.jpg	GRAPHIC	39726
	Complete submission text file	0001193125-18-333095.txt		993108

Mailing Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135

Business Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135 617-225-0096

PROTEOSTASIS THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: S-3 | Act: 33 | File No.: 333-228529 | Film No.: 181199679
SIC: 2834 Pharmaceutical Preparations